305-468-3314
3650 NW 82nd Avenue, Suite 502, Miami, FL 33166

Kidney cancer occurs when cancerous cells form in the tissue of one or both kidneys, most often as renal cell carcinoma — the form responsible for roughly 85% to 90% of all kidney cancer cases. An estimated 80,450 new cases are diagnosed nationally each year, and the outlook is genuinely encouraging for most patients: roughly two-thirds are caught while the cancer is still confined to the kidney, where the 5-year relative survival rate reaches 93.3%.
Delaware has solid regional cancer care, including programs at Bayhealth and ChristianaCare — if you’re already connected to one, continuing care there is entirely reasonable. Dr. Shirin Razdan, a board-certified urologic oncologist and robotic surgeon in Miami, also treats patients who travel from Delaware specifically for her subspecialty expertise in Single Port robotic surgery for kidney cancer.
| Statistic | What the Data Shows |
| New U.S. cases annually | About 80,450, among the 10 most common cancers nationwide |
| Most common kidney cancer type | Renal cell carcinoma (RCC), accounting for roughly 85% to 90% of cases |
| Diagnosed at localized stage | About 65.7% of cases |
| 5-year survival, localized stage | 93.3% |
| 5-year survival, all stages combined | 79.2% |
| Sex distribution | About twice as common in men as in women |
| Common risk factors | Smoking, obesity, high blood pressure, family history |
Kidney cancer typically begins in the lining of the small tubes inside the kidney — the organs responsible for filtering blood and producing urine. It affects both men and women, though it’s about twice as common in men. Early kidney cancer usually causes no noticeable symptoms, which is a major reason the overall localized-stage survival rate is so favorable — many cases are caught incidentally during imaging done for an unrelated reason, before symptoms ever appear.
Symptoms to Watch For
Risk Factors
| Treatment | What It Involves | Best For |
| Active surveillance | Regular imaging monitors a small tumor without immediate treatment | Small, slow-growing tumors, particularly in older patients |
| Partial nephrectomy | Removes only the cancerous portion, preserving healthy kidney tissue | Smaller, well-localized tumors |
| Radical nephrectomy | Removes all or part of the affected kidney | Larger or more advanced tumors |
| Robotic / Single Port nephrectomy | Minimally invasive surgery offering smaller incisions and quicker recovery than open or standard laparoscopic approaches | Most appropriately selected partial and radical nephrectomy candidates |
| Targeted therapy | Medication that attacks specific genes or proteins driving cancer cell growth, without harming surrounding healthy cells | Cases where surgery alone isn’t curative |
| Immunotherapy | Stimulates the body’s own immune system to recognize and attack cancer cells | Advanced-stage disease that has spread beyond the kidney |
| Radiation therapy | Less commonly used for kidney cancer itself | Cases where cancer has spread to bones or the brain |
| Chemotherapy | Not a primary kidney cancer treatment, since kidney cancer cells often respond poorly to it | Select advanced or metastatic cases where other options aren’t suitable |
For a broader look at how these options are typically weighed against each other, see our complete guide to kidney cancer treatment options.
Dr. Razdan specializes in robotic-assisted nephrectomy, both partial and radical, performed through small incisions for a quicker recovery than traditional open surgery. Her Single Port technique goes further, completing the procedure through one small incision — a capability still concentrated among a relatively small number of surgeons nationally.
Treatment planning starts with a detailed review of your imaging — CT scans, MRIs, and biopsy results, when available — to precisely map tumor size, location, and extent before recommending a surgical or non-surgical path forward.
When cancer has spread and requires targeted therapy, immunotherapy, or radiation as part of a broader treatment plan, Dr. Razdan coordinates with medical oncology and radiation oncology partners so your surgical and systemic care remain connected.
A kidney cancer diagnosis takes an emotional toll as well as a physical one. Patients are guided through diagnosis, treatment, and follow-up with clear explanations of what to expect, the benefits of each option, and potential side effects along the way.

If you’re already connected to a Delaware cancer program, continuing care there is a reasonable choice — these centers offer genuine strengths close to home. Traveling to Miami tends to make the most sense for patients specifically seeking Single Port or highly subspecialized robotic expertise, or those who want a second opinion before committing to a treatment plan. Either way, it’s worth asking any surgeon directly how many robotic or Single Port procedures they perform annually, and whether a kidney-preserving approach fits your specific tumor.
Kidney cancer typically shows no symptoms in its early stages. As it progresses, signs can include blood in the urine, pain in the side or lower back, fatigue, unexplained weight loss, fever, anemia, or swelling in the ankles or legs.
Early detection through imaging or regular checkups is essential. If you’re diagnosed, your care team will help determine the most effective treatment approach based on your tumor’s size, location, and stage.
Major risk factors include smoking and obesity, chronic conditions like high blood pressure and severe kidney disease, family history and genetics, and environmental exposures such as certain chemicals or long-term use of some pain medications.
Yes, especially when it’s localized to the kidney and hasn’t spread — surgery is often curative in these cases, with a 93.3% five-year survival rate. For more advanced disease, targeted therapy and immunotherapy can help manage the disease and extend survival, though outcomes vary more by individual case.
Across all stages combined, the 5-year relative survival rate is 79.2%. Learn more in our complete guide to kidney cancer symptoms, survival rates, and treatment cost.
Not necessarily — many out-of-state patients begin with a remote review of imaging and records to determine whether Single Port or robotic surgery makes sense for their case before planning travel.
No. Small, low-risk tumors may be appropriate for active surveillance or ablation instead, while larger or more advanced tumors generally require surgical removal.
Yes — a second opinion is considered good medical practice for any cancer diagnosis and can help confirm your diagnosis and clarify your options, regardless of which provider you ultimately choose.
To learn more about Dr. Razdan’s background and surgical approach, visit her about page, or read more on whether kidney cancer is curable for your specific stage.
© 2025 Miami Robotic Surgery. All rights reserved.